Lawmaker questions FDA priorities, suggests industry ties
Tainted batches of heparin may have raised concerns with the general public, but a recent Reuters report suggests the U.S. Food and Drug Administration (FDA) would rather focus on giving product promotion advice to companies and journal reprints to physicians than food and drug safety scares.